Cited by 342Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingNeurological diseases and metabolism

The DOI matches its Crossref record; 46 of the 49 references it cites were found in a registry or an index.

PINK1 protein in normal human brain and Parkinson's disease

Gandhi, S.·2006·Brain

DOI 10.1093/brain/awl114

Open this paper in CoChat — free account

Abstract

Parkinson's disease is a common incurable neurodegenerative disease whose molecular aetiology remains unclear. The identification of Mendelian genes causing rare familial forms of Parkinson's disease has revealed novel proteins and pathways that are likely to be relevant in the pathogenesis of sporadic Parkinson's disease. Recently, mutations in a novel gene, PINK1, encoding a 581 amino acid protein with both mitochondrial targeting and serine/threonine kinase domains, were identified as a cause of autosomal recessive parkinsonism. This provided important evidence for the role of the mitochondrial dysfunction and kinase pathways in neurodegeneration. In this study, we report the first characterization of the PINK1 protein in normal human and sporadic Parkinson's brains, in addition to Parkinson's cases with heterozygous PINK1 mutations. The possible role of the PINK1 protein was also assessed in a number of neurodegenerative diseases characterized by proteinaceous inclusions. For these studies, rabbit polyclonal antibodies were raised against two peptide sequences within the N-terminal hydrophilic loops of PINK1 protein. Using immunohistochemistry and western blotting we were able to demonstrate that PINK1 is a ubiquitous protein expressed throughout the human brain and it is found in all cell types showing a punctate cytoplasmic staining pattern consistent with mitochondrial localization. Fractionation studies of human and rat brain confirm that PINK1 is localized to the mit…

Integrity signals

Registry

Crossref · 10.1093/brain/awl114

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
α-Synuclein in Lewy bodies
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,770
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854

Show all 49 references

Sorted by citations

Items 201–300 of 339

Autonomic dysfunction in genetic forms of synucleinopathies
Chelban, V., Vichayanrat, E., Schottlaende, L., Iodice, V., & Houlden, H. (2018) · Movement Disorders · doi:10.1002/mds.27343 · Cited by 28
The identified clinical features of Parkinson's disease in homo-, heterozygous and digenic variants of PINK1
Hayashida, A., Li, Y., Yoshino, H., Daida, K., Ikeda, A., Ogaki, K., Fuse, A., Mori, A., Takanashi, M., Nakahara, T., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.06.017 · Cited by 28
Evaluation of PINK1 variants in Indian Parkinson's disease patients
Biswas, A., Sadhukhan, T., Majumder, S., Misra, A. K., Das, S. K., Ray, K., & Ray, J. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.10.005 · Cited by 28
Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons
Zhou, Z., Refai, F. S., Xie, S. P., Ng, S. H., Chan, C. H. S., Ho, P., Zhang, X. D., Lim, T. M., & Tan, E. K. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.12.015 · Cited by 28
Genetics of Parkinson’s Disease - A Clinical Perspective
Cheon, S., Chan, L., Chan, D. K. Y., & Kim, J. W. (2012) · Journal of Movement Disorders · doi:10.14802/jmd.12009 · Cited by 27
What Have PINK1 and HtrA2 Genes Told Us about the Role of Mitochondria in Parkinson's Disease?
Plun‐Favreau, H., Gandhi, S., Wood‐Kaczmar, A., Deas, E., Yao, Z., & Wood, N. W. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.032 · Cited by 28
Self-citation
Fishing for Parkinson’s Disease: A review of the literature
Ünal, İ., & Emekli‐Alturfan, E. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.01.015 · Cited by 29
Protein degradation in Parkinson disease revisited: it’s complex
Li, H., & Guo, M. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38619 · Cited by 25
Potential Role of Mic60/Mitofilin in Parkinson’s Disease
Laar, V. S. V., Otero, P. A., Hastings, T. G., & Berman, S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00898 · Cited by 25
Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils
Creed, R. B., & Goldberg, M. S. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.04.032 · Cited by 24
Considerations Regarding the Etiology and Future Treatment of Autosomal Recessive Versus Idiopathic Parkinson Disease
Kitada, T., Tomlinson, J. J., Ao, H. S., Grimes, D. A., & Schlossmacher, M. G. (2012) · Current Treatment Options in Neurology · doi:10.1007/s11940-012-0175-8 · Cited by 23
Aspects of innate immunity and Parkinson's disease
Huang, Y., & Halliday, G. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00033 · Cited by 22
Existence of Pink1 Antisense RNAs in Mouse and Their Localization
Chiba, M., Kiyosawa, H., Hiraiwa, N., Ohkohchi, N., & Yasue, H. (2009) · Cytogenetic and Genome Research · doi:10.1159/000251963 · Cited by 22
Mitochondria: Prospective Targets for Neuroprotection in Parkinson’s Disease
Yadav, A., Agarwal, S., Tiwari, S. K., & Chaturvedi, R. K. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140305224545 · Cited by 22
Whole-Transcriptome Analysis of Mouse Models with MPTP-Induced Early Stages of Parkinson’s Disease Reveals Stage-Specific Response of Transcriptome and a Possible Role of Myelin-Linked Genes in Neurodegeneration
Alieva, A. K., Zyrin, V. S., Rudenok, M. M., Kolacheva, A. A., Shulskaya, M. V., Ugryumov, M. V., Slominsky, P. A., & Shadrina, M. I. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0907-1 · Cited by 22
Mechanisms of neurodegeneration in Parkinson’s disease: keep neurons in the PINK1
Brunelli, F., Valente, E. M., & Arena, G. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111277 · Cited by 22
A zebrafish model of PINK1 deficiency reveals key pathway dysfunction including HIF signaling
Priyadarshini, M., Tuimala, J., Chen, Y. C., & Panula, P. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.02.002 · Cited by 23
Assessing the prevalence of PINK1 genetic variants in South African patients diagnosed with early- and late-onset Parkinson’s disease
Keyser, R. J., Lesage, S., Brice, A., Carr, J. A., & Bardien, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.049 · Cited by 21
Roles of PINK1 in regulation of systemic growth inhibition induced by mutations of PTEN in Drosophila
Han, Y., Zhuang, N., & Wang, T. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108875 · Cited by 21
Rab GTPases in Parkinson's disease: a primer
Ordóñez, A. J. L., Fasiczka, R., Naaldijk, Y., & Hilfiker, S. (2021) · Essays in Biochemistry · doi:10.1042/ebc20210016 · Cited by 20
The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons
Mamais, A., Sanyal, A., Fajfer, A., Zykoski, C. G., Guldin, M., Riley-DiPaolo, A., Subrahmanian, N., Gibbs, W. S., Lin, S., & LaVoie, M. J. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.01.001 · Cited by 20
PINK1 polymorphism IVS1−7 A→G, exposure to environmental risk factors and anticipation of disease onset in Brazilian patients with early-onset Parkinson's Disease
Godeiro-Junior, C. D. O., Aguiar, P. D. C., Felicio, A. C., Barsottini, O. G. P., Silva, S. M. A., Borges, V., de Andrade, L. A. F., & Ferraz, H. B. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.064 · Cited by 20
Parkinson’s disease: what the model systems have taught us so far
Ghatak, S., Trudler, D., Dolatabadi, N., & Ambasudhan, R. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0960-6 · Cited by 20
PINK1 activation–turning on a promiscuous kinase
Aerts, L., Strooper, B. D., & Morais, V. A. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150002 · Cited by 21
Cytosolic PTEN-induced Putative Kinase 1 Is Stabilized by the NF-κB Pathway and Promotes Non-selective Mitophagy
Lim, G. G. Y., Chua, D. S. K., Basil, A. H., Chan, H.-Y., Chai, C., Arumugam, T. V., & Lim, K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.622399 · Cited by 19
Parkinson’s disease research: adopting a more human perspective to accelerate advances
Marshall, L. J., & Willett, C. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.09.010 · Cited by 19
Common variants in the PARL and PINK1 genes increase the risk to leprosy in Han Chinese from South China
Wang, D., Zhang, D., Feng, J., Li, G.-D., Li, X.-A., Yu, X.-F., Long, H., Li, Y., & Yao, Y. (2016) · Scientific Reports · doi:10.1038/srep37086 · Cited by 18
Protein Phosphatase 1γ Isoforms Linked Interactions in the Brain
Esteves, S. L. C., Korrodi‐Gregório, L., Cotrim, C. Z., van Kleeff, P. J. M., Domingues, S. C., Silva, O. A. B. D. C. E., Fardilha, M., & Silva, E. F. D. C. E. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9902-6 · Cited by 18
R492X mutation in PTEN-induced putative kinase 1 induced cellular mitochondrial dysfunction and oxidative stress
Yuan, X.-L., Guo, J., Shi, Z., Zhi-qian, X., Yan, X., Zhao, B., & Tang, B. (2010) · Brain Research · doi:10.1016/j.brainres.2010.06.005 · Cited by 17
Can the disease course in Parkinson’s disease be slowed?
Korczyn, A. D., & Hassin‐Baer, S. (2015) · BMC Medicine · doi:10.1186/s12916-015-0534-x · Cited by 17
SIAH proteins regulate the degradation and intra‐mitochondrial aggregation of PINK1 : Implications for mitochondrial pathology in Parkinson's disease
Elghani, F. A., Safory, H., Hamza, H., Savyon, M., Farhoud, M., Toren-Hershkoviz, M., Vitic, Z., Ebanks, K., Shani, V., Bisharat, S., et al. (2022) · Aging Cell · doi:10.1111/acel.13731 · Cited by 16
Function of α-synuclein and PINK1 in Lewy body dementia (Review)
Minami, A., NAKANISHI, A., Matsuda, S., Kitagishi, Y., & Ogura, Y. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1980 · Cited by 16
The Genetics of Alzheimer’s Disease and Parkinson’s Disease
Bekris, L. M., Yu, C., Bird, T. D., & Tsuang, D. W. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_21 · Cited by 16
Dysfunction of Mitochondrial Respiratory Chain Complex I in Neurological Disorders: Genetics and Pathogenetic Mechanisms
Petruzzella, V., Sardanelli, A. M., Scacco, S., Panelli, D., Papa, F., Trentadue, R., & Papa, S. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2869-1_17 · Cited by 16
Correction: PINK1 Is Necessary for Long Term Survival and Mitochondrial Function in Human Dopaminergic Neurons
Wood‐Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A. Y., Miljan, E., Keen, G., Stanyer, L., Hargreaves, I. P., Klupsch, K., Deas, E., et al. (2008) · PLoS ONE · doi:10.1371/annotation/17d5aaa1-c6d8-4aad-a9a4-56b2c1220c83 · Cited by 16
Self-citation
Mitochondrial dysfunction and oxidative damage in the molecular pathology of Parkinson’s disease
Shadrina, M. I., & Slominsky, P. A. (2008) · Molecular Biology · doi:10.1134/s0026893308050099 · Cited by 15
Pathogenic Aspects and Therapeutic Avenues of Autophagy in Parkinson’s Disease
Kinet, R., & Dehay, B. (2023) · Cells · doi:10.3390/cells12040621 · Cited by 15
Identification of key pathways and transcription factors related to Parkinson disease in genome wide
Zhang, B., Cuiping, X., Lin, Q., & Huang, J. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-1985-1 · Cited by 15
Transcranial brain sonography findings in Parkinson’s disease: implications for pathogenesis, early diagnosis and therapy
Walter, U. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.41 · Cited by 15
Behavioral testing regimens in genetic-based animal models of Parkinson's disease: Cogencies and caveats
Bury, A. G., & Pienaar, I. S. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.03.007 · Cited by 14
Novel approaches to counter protein aggregation pathology in Parkinson's disease
Stott, S., Wyse, R. K. H., & Brundin, P. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.007 · Cited by 16
Genomic variants at the PINK1 locus are associated with transcript abundance and plasma nonesterified fatty acid concentrations in European whites
Franks, P. W., Schéele, C., Loos, R. J. F., Nielsen, A. R., Finucane, F. M., Wahlestedt, C., Pedersen, B. K., Wareham, N. J., & Timmons, J. A. (2008) · The FASEB Journal · doi:10.1096/fj.08-107086 · Cited by 14
Expression of PINK1 in the brain, eye and ear of mouse during embryonic development
d’Amora, M., Angelini, C., Marcoli, M., Cervetto, C., Kitada, T., & Vallarino, M. (2010) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2010.11.004 · Cited by 14
PINK1 Type of Young-Onset Parkinson Disease
Schneider, S. A., & Klein, C. (2014) · Europe PMC (PubMed Central) · Cited by 13
Rethinking ‘rare’ PINK1 Parkinson's disease: A meta-analysis of geographical prevalence, phenotypic diversity, and α-synuclein pathology
Yin, E. P., & Dieriks, B. V. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x241304814 · Cited by 12
The PINK1-Mediated Crosstalk between Neural Cells and the Underlying Link to Parkinson’s Disease
Leites, E. P., & Morais, V. A. (2021) · Cells · doi:10.3390/cells10061395 · Cited by 12
Dichloroacetate stimulates changes in the mitochondrial network morphology via partial mitophagy in human SH-SY5Y neuroblastoma cells
Reguera, D. P., Alán, L., Olejár, T., & Ježek, P. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2953 · Cited by 12
PINK1 suppresses alpha-synuclein-induced neuronal injury: a novel mechanism in protein phosphatase 2A activation
Yang, W., Wang, X., Liu, J., Duan, C., Gao, G., Lu, L., Yu, S., & Yang, H. (2017) · Oncotarget · doi:10.18632/oncotarget.21554 · Cited by 12
Pink1
Looyenga, B. D., DeHaan, A. M., & MacKeigan, J. P. (2008) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a003826.01 · Cited by 11
Abnormal Development of Glutamatergic Synapses Afferent to Dopaminergic Neurons of the Pink1−/− Mouse Model of Parkinson’s Disease
Pearlstein, É., Michel, F. J., Save, L., Ferrari, D. C., & Hammond, C. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00168 · Cited by 11
New insights on the mitochondrial proteome plasticity in Parkinson's disease
Aroso, M., Ferreira, R. M., Freitas, A., Vitorino, R. M. P., & Gómez-Lázaro, M. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500092 · Cited by 10
Mitochondria and Parkinson's Disease
Simon, D. K., Chu, C. T., & Swerdlow, R. H. (2011) · Parkinson s Disease · doi:10.4061/2011/261791 · Cited by 8
Parkinson's disease‐associated PINK1 G309D mutation increases abnormal phosphorylation of T au
Ye, M., Zhou, D., Zhou, Y., & Sun, C. (2015) · IUBMB Life · doi:10.1002/iub.1367 · Cited by 8
Mitochondrial Precursor Overaccumulation Stress
Coyne, L. P., & Chen, X. J. (2026) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-051424-061016 · Cited by 7
Differential distribution of PINK1 and Parkin in the primate brain implies distinct roles
Liu, Y., Huang, W., Wen, J., Xiong, X., Xu, T., Wang, Q., Chen, X., Zhao, X., Li, S., Li, X., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01140 · Cited by 7
Parkinson Disease: from Pathophysiology to the Animal Models
Vazifekhah, S., & Karimzadeh, F. (2016) · The Neuroscience Journal of Shefaye Khatam · doi:10.18869/acadpub.shefa.4.3.91 · Cited by 7
Neuroinflammation as a Potential Mechanism Underlying Parkinsons Disease
Cebrián, C., & Sulzer, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00008-0 · Cited by 7
Novel P-TEN-induced putative kinase 1 (PINK1) variant in Indian Parkinson’s disease patient
Halder, T., Raj, J., Sharma, V., & Das, P. K. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.08.021 · Cited by 6
Antioxidant modulation in restoring mitochondrial function in neurodegeneration
Arrozi, A. P., Ngah, W. Z. W., Yusof, Y. A. M., Damanhuri, H. A., & Makpol, S. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1178261 · Cited by 7
Differentiation of Human Pluripotent Stem Cells Into Specific Neural Lineages
Chang, C.-Y., Ting, H.-C., Liu, C.-A., Su, H., Chiou, T., Harn, H., Lin, S., & Ho, T. (2021) · Cell Transplantation · doi:10.1177/09636897211017829 · Cited by 6
On the key role played by altered protein conformation in Parkinson’s disease
Agnati, L. F., Baldelli, E., Andreoli, N., Woods, A. S., Vellani, V., Marcellino, D. J., Guidolin, D., & Fuxé, K. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0072-1 · Cited by 6
The Role of Astrocytes in Parkinson’s Disease
Stevens, C. H., & Halliday, G. M. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_5 · Cited by 5
PINK1: One Protein, Multiple Neuroprotective Functions
Valente, E. M., Michiorri, S., Arena, G., & Gelmetti, V. (2009) · Future Neurology · doi:10.2217/fnl.09.39 · Cited by 4
Targeting protein kinases in Parkinson’s disease: the emerging role of phytoconstituents
Joshi, D., Kulkarni, M., Parekh, P., Shah, S., Greig, N. H., & Acharya, S. P. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2531356 · Cited by 4
Based on Virtual Screening and Simulation Exploring the Mechanism of Plant-Derived Compounds with PINK1 to Postherpetic Neuralgia
Guo, W., Zhang, B., Liu, M., Zhang, J., & Feng, Y. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04098-4 · Cited by 3
PINK1 (PARK6) and Parkinson's Disease
Valente, E. M., & Ferraris, A. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00005-2 · Cited by 3
Genetics of Parkinson's Disease—An Overview
Klein, C. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00002-7 · Cited by 3
Mitophagy
King, L., & Plun‐Favreau, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803783-6.00005-5 · Cited by 6
Zebrafish as a model of Parkinson's disease
Sallinen, V. J. (2009) · Työväentutkimus Vuosikirja · Cited by 3
Mitochondrial protein import stress augments α-synuclein aggregation and neurodegeneration independent of bioenergeticsPreprint
Coyne, L. P., Rana, A., Wang, X., Bhagwagar, S. Z., Umino, Y., Solessio, E. C., Middleton, F. A., & Chen, X. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.20.508793 · Cited by 3
A beginner’s guide into curated analyses of open access datasets for biomarker discovery in neurodegeneration
Moreira, D. G., & Jan, A. (2023) · Scientific Data · doi:10.1038/s41597-023-02338-1 · Cited by 4
Targeting the Rho/ROCK Signaling Pathway Mitigates Mitochondrial Dysfunction in 6-OHDA-Induced Models of Parkinson’s Disease, Both In Vivo and In Vitro
Güçlü, E., İnan, S. Y., Güneş, C. E., & Vural, H. C. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05419-x · Cited by 2
The Importance of Olfactory and Motor Endpoints for Zebrafish Models of Neurodegenerative Disease
Shamchuk, A. L., & Tierney, K. B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00027-0 · Cited by 2
In vivo Effects of Salicornia herbacea and Calystegia soldanella Extracts for Memory Improvement
Sang, J., Poudel, S., & Lee, Y. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2312.12045 · Cited by 2
Phosphorylation Events in Selective Mitophagy: Possible Biochemical Markers?
Zhang, W., Wu, H., Liu, L., Zhu, Y., & Chen, Q. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0033-8 · Cited by 2
TIGARB CAUSES MITOCHONDRIAL DYSFUNCTION AND NEURONAL LOSS IN PINK1 DEFICIENCY
Bandmann, O. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306573.16 · Cited by 2
Overexpression of N141I PS2 increases γ-secretase activity through up-regulation of Presenilin and Pen-2 in brain mitochondria of NSE/hPS2m transgenic mice
Yun, W. B., Park, J. J., Kim, J. E., Sung, J. E., Lee, H. A., Lee, J. H., Bae, C. J., & Hwang, D. Y. (2016) · Laboratory Animal Research · doi:10.5625/lar.2016.32.4.249 · Cited by 2
The Importance of Olfactory and Motor Endpoints for Zebrafish Models of Neurodegenerative Disease
Shamchuk, A. L., Allison, W. T., & Tierney, K. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00021-8 · Cited by 2
Papel de la función mitocondrial en las enfermedades neurodegenerativas
Rodríguez‐Violante, M., Cervantes‐Arriaga, A., Vargas‐Cañas, S., & Corona, T. (2010) · Archivos de Neurociencias · Cited by 2
Loss of PINK1 or Parkin Function Results in a Progressive Loss of Mitochondrial Function
Taanman, J., & Protasoni, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812146-7.00007-x · Cited by 2
Modeling of Human Parkinson’s Disease in Fly
Chatterjee, S., Bhaskar, P. K., Mukherjee, A., & Mutsuddi, M. (2019) · Springer eBooks · doi:10.1007/978-981-13-2218-1_10 · Cited by 2
Mitochondrial protein import stress augments α-synuclein aggregation and neural damage independent of bioenergeticsPreprint
Chen, X. J., Coyne, L. P., Rana, A., Wang, X., Bhagwagar, S. Z., Umino, Y., Solessio, E. C., & Middleton, F. A. (2025) · Research Square · doi:10.21203/rs.3.rs-3136613/v1 · Cited by 2
Etiology, Pathology, and Pathogenesis
Geser, F., Jellinger, K. A., Köllensperger, M., Stefanova, N., & Wenning, G. K. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00019-2 · Cited by 2
AI-augmented prediction of high-risk PINK1 variants associated with Parkinson’s disease: integrating multilayered bioinformatics, MD simulation, and deep learning
Rehman, H. U., Warraich, D. A., Rehman, A., Fatima, I., Meng, Y., Aldaw, M., Ding, Y., Zhang, R., Ni, Y., He, Z., et al. (2025) · Methods · doi:10.1016/j.ymeth.2025.08.014 · Cited by 1
Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations
Padilla, A. L., Lanciego, J. L., Vila, M., de Castro, F., Pozo, D., de Fonseca, F. R., Serrano, A., Sáez‐Valero, J., Núñez, L., Villalobos, C., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.03.031 · Cited by 1
Peripheral nervous system involvement in Parkinson’s disease: Peripheral neuropathy, neuromuscular junction dysfunction, and clinical implications
Qian, J., Wang, H., Zhang, Y., Cui, J., Cao, Y., Xie, J., & Shi, L. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106840 · Cited by 1
Mito-liposomes: A potential delivery strategy for mitochondrial targeting via membrane fusion activity
Zhou, Y. M. (2012) · Cited by 1
6Chapter Micronutrients for the Prevention of Diabetes and Improvement of the Standard Therapy
Prasad, K. N. (2010) · CRC Press eBooks · doi:10.1201/ebk1439821060-11 · Cited by 1
Experimental models for evaluation of direct nose-to-brain drug delivery
Agnihotri, V. V., Gorle, A. P., Pardeshi, C. V., & Surana, S. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00021-7 · Cited by 1
A Case Report on a Novel PINK1 Gene Mutation in a Female with a Neurodegenerative Disorder
Bandla, S. S., Srilekha, A., Karchalkar, P., Gayatri, S., & Ananthapur, V. (2022) · EMJ Neurology · doi:10.33590/emjneurol/21-00206 · Cited by 1
Probiotics protect against progressive deterioration of motor functions and Parkinson's disease
Kumari, R., Makwana, M., & Hati, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95735-9.00047-4 · Cited by 1
Animal Models for PD and ALS
Kuenstling, M. V., Szlachetka, A. M., & Mosley, R. L. (2013) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-1-4614-8794-4_34 · Cited by 1
Mutual Neurotoxic Mechanisms Controlling Manganism and Parkisonism
Roth, J. A. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622383-00221 · Cited by 1
Micronutrients for the Prevention and Improvement of the Standard Therapy for Parkinson’s Disease
Prasad, K. N. (2019) · CRC Press eBooks · doi:10.1201/9780429243462-10 · Cited by 1
Biomarker detection of Parkinson’s disease: therapy and treatment using nanomaterials
Nanda, R., Panda, P., & Mishra, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817923-9.00017-1 · Cited by 1
LRRK2 genetics and expression in the Parkinsonian brain
Sharma, S. (2010) · UCL Discovery (University College London) · Cited by 1
Tetrahydroisoquinoline Neurotoxins in Parkinson Disease
DeCuypere, M. G. (2010) · doi:10.21007/etd.cghs.2010.0067 · Cited by 1
Genetic Models of Parkinson’s Disease
Palubinsky, A. M., Lizama, B. N., Miller, D. L., & McLaughlin, B. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800228-5.00014-5 · Cited by 1
Faculty Opinions recommendation of PINK1 cleavage at position A103 by the mitochondrial protease PARL.
Zeviani, M., & Ghezzi, D. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.7519969.8027061 · Cited by 1
Modelling Parkinson’s Disease Pre-Clinically: A Novel Virus-Fibril Inducible Mouse Model Exploring Disease Characteristics and Therapeutic Intervention via Metabotropic Glutamate Receptor 5 Negative Allosteric Modulation
Bureau, S. C. (2022) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2022-14889 · Cited by 1

Authors: Gandhi, S.
Affiliations: UCL Queen Square Institute of Neurology (GB)
Corresponding author: Gandhi, S.
ORCID: Gandhi, S.
Venue: Brain
Publisher: Oxford University Press (OUP)
Published: 2006-07-01
Volume: 129
Issue: 7
Pages: 1720-1731
ISSN: 0006-8950 (ISSN-L)
1460-2156
DOI: 10.1093/brain/awl114
OpenAlex: W2131641631
Cited by: 342
References: 49
Citations by year: 2026: 6 · 2025: 8 · 2024: 11 · 2023: 4 · 2022: 8 · 2021: 11 · 2020: 9 · 2019: 12 · 2018: 9 · 2017: 10 · 2016: 14 · 2015: 12 · 2014: 17 · 2013: 22 · 2012: 22
FWCI: 24.12
Type: journal article
Language: en
Open access: closed
Locations: Brain (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: Wellcome Trust
Parkinson's UK (G-4062)
Cotton Research and Development Corporation
Medical Research Council
Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology,University College London
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords: PINK1, Parkinson's disease, sporadic Parkinson's disease, mitochondrial dysfunction, Lewy bodies, mitochondrial localization, neurodegeneration, autosomal recessive parkinsonism, neurofibrillary tangles, alpha-synuclein inclusions, multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, Alzheimer's disease, serine/threonine kinase
MeSH terms: PTEN-Induced Putative Kinase, Alzheimer Disease, Animals, Brain, Carbonates, Female, Heterozygote, Humans, Immunoenzyme Techniques, Male, Middle Aged, Mitochondria, Mutation, Parkinson Disease, Protein Kinases, Submitochondrial Particles, Rats, Wistar, Multiple System Atrophy, Lewy Body Disease, Mitochondrial Membranes, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

PINK1 protein in normal human brain and Parkinson's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks